Quarterly report [Sections 13 or 15(d)]

Stockholders’ Equity - Schedule of Activity for the Company’s IPO Warrants (Details)

v3.26.3
Stockholders’ Equity - Schedule of Activity for the Company’s IPO Warrants (Details) - Warrant [Member]
9 Months Ended 12 Months Ended
Sep. 30, 2026
USD ($)
$ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Schedule of Activity for the Company’s IPO Warrants [Line Items]    
Number of Shares Underlying Outstanding Options Beginning (in Shares) | shares 478,419  
Weighted-Average Exercise Price Beginning (in Dollars per share) | $ / shares $ 60  
Weighted- Average Remaining Contractual Term (in Years), Outstanding at Beginning 6 months 14 days
Aggregate Intrinsic Value, Outstanding at Beginning | $  
Number of Shares Underlying Outstanding Warrants, Warrants granted | shares  
Weighted- Average Exercise Price, Warrants granted | $ / shares  
Weighted- Average Remaining Contractual Term (in Years), Warrants granted  
Aggregate Intrinsic Value, Warrants granted | $  
Number of Shares Underlying Outstanding Warrants, Warrants exercised | shares  
Weighted- Average Exercise Price, Warrants exercised  
Weighted- Average Remaining Contractual Term (in Years), Warrants exercised  
Aggregate Intrinsic Value, Warrants exercised | $  
Number of Shares Underlying Outstanding Warrants, Warrants expired | shares (478,419)  
Weighted- Average Exercise Price, Warrants expired  
Weighted- Average Remaining Contractual Term (in Years), Warrants expired  
Aggregate Intrinsic Value, Warrants expired | $  
Number of Shares Underlying Outstanding Options Ending (in Shares) | shares 478,419
Weighted-Average Exercise Price Ending (in Dollars per share) | $ / shares $ 60
Weighted- Average Remaining Contractual Term (in Years), Outstanding at Ending 6 months 14 days
Aggregate Intrinsic Value, Outstanding at Ending | $